|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
LS ARK Genomic Revolution Tracker ETP Securities
XS2399368062
USD / Acc. / Retail
|
10.12.2021
4,6 Jahre
|
1,00 |
+20,17% |
+60,53% |
+16,42% |
N/A |
|
WEALTHGATE Biotech Fund
DE000A3ETA12
USD / Dist. / Retail
|
14.02.2024
2,4 Jahre
|
5,28 |
+20,34% |
+76,91% |
N/A |
N/A |
|
Abaris Biotechnology Opportunities
LU2210105313
USD / Acc. / Retail
|
30.10.2020
5,7 Jahre
|
8,04 |
+18,08% |
+82,48% |
+101,97% |
-0,76% |
|
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
USD / Acc. / Retail
|
18.01.2018
8,5 Jahre
|
17,90 |
+12,40% |
+45,00% |
+31,83% |
+17,33% |
|
WisdomTree BioRevolution UCITS ETF
IE000O8KMPM1
USD / Acc. / Retail
|
03.12.2021
4,6 Jahre
|
18,47 |
+25,55% |
+64,35% |
+19,13% |
N/A |
|
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund
LU1540961759
USD / Acc. / Retail
|
30.12.2011
14,6 Jahre
|
22,59 |
+13,96% |
+59,29% |
+62,23% |
+40,95% |
|
Protea Fund - Sectoral Biotech Opportunities Fund
LU1176840327
USD / Acc. / Retail
|
27.02.2015
11,4 Jahre
|
26,52 |
+9,99% |
+52,76% |
+37,64% |
+14,77% |
|
Global X Genomics & Biotechnology UCITS ETF
IE00BM8R0N95
USD / Acc. / Retail
|
02.11.2021
4,7 Jahre
|
34,68 |
+27,68% |
+74,70% |
+13,05% |
N/A |
|
PPF ("PMG Partners Funds") - Helix Biotechnology Fund
LU1230343250
USD / Acc. / Retail
|
21.10.2015
10,8 Jahre
|
35,34 |
+31,26% |
+93,36% |
+61,61% |
+4,96% |
|
Galileo - Biotech Innovation Fund
LU2226244361
USD / Acc. / Retail
|
31.03.2021
5,3 Jahre
|
46,59 |
+25,73% |
+80,99% |
+14,79% |
-52,52% |